🇦🇺·5d agoIndustry
Our Commitment to the Hemophilia B Community: An Update on HEMGENIX® (etranacogene dezaparvovec-drlb) Availability
Publisher
C
CSL Behring
Australia
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on newsroom.csl.com
Leave the platform to read the original full article on the publisher site.
Source: CSL Behring
Scope: Industry
Related coverage
More related coverage
AHA (Heart Association)·1d ago
Hospitals drive progress in Japan’s heart failure care
RAPS News·1d ago
This Week at FDA: FDA seeks input on CNPV, new approvals, and more
Skpharmteco·1d ago
Biocatalysis 101: A Faster, Greener, and More Cost-Effective Approach to API Manufacturing
RAPS News·1d ago